A pair of respected medical journals published studies within the last couple of months that linked the expectant mother's use of selective serotonin reuptake inhibitor antidepressants with certain birth defects. The findings were released while SSRI antidepressant lawsuits have been filed against the makers of some of these popular drugs. Plaintiffs alleged the birth defects connection.
Study suggests simple way to improve chemo drug performance
Chemotherapy is a powerful tool in the fight against many different forms of cancer. The problem with it is that the chemicals that are used can be deadly. Doctors don't want to give patients too much of the stuff. If they do, the intended cure could be worse than the disease.
Study suggests simple way to improve chemo drug performance
Chemotherapy is a powerful tool in the fight against many different forms of cancer. The problem with it is that the chemicals that are used can be deadly. Doctors don't want to give patients too much of the stuff. If they do, the intended cure could be worse than the disease.
New studies released on Xarelto bleeding
Medical science and countless victims have known all about the risks of gastrointestinal bleeding associated with the anticoagulant Xarelto (rivaroxaban). The bleeding risk is at the center of Xarelto lawsuits that are being filed across the nation by bleeding victims or by their surviving next-of-kin who have sought legal counsel and who have decided not to suffer in silence. Nevertheless, a pair of studies published in 2015 focus - if you will - on eye bleeding.
New studies released on Xarelto bleeding
Medical science and countless victims have known all about the risks of gastrointestinal bleeding associated with the anticoagulant Xarelto (rivaroxaban). The bleeding risk is at the center of Xarelto lawsuits that are being filed across the nation by bleeding victims or by their surviving next-of-kin who have sought legal counsel and who have decided not to suffer in silence. Nevertheless, a pair of studies published in 2015 focus - if you will - on eye bleeding.
Improving the way drugs are tested and marketed
Sometimes there is good news and not-so-good news in a trial that tests the effectiveness and safety of a potential new drug. When the sponsor of the trial either downplays or disregards the unflattering information about an unreasonable health risk, it's the patient and the patient's family who get the worst news of all.
Improving the way drugs are tested and marketed
Sometimes there is good news and not-so-good news in a trial that tests the effectiveness and safety of a potential new drug. When the sponsor of the trial either downplays or disregards the unflattering information about an unreasonable health risk, it's the patient and the patient's family who get the worst news of all.
Testosterone product labels updated
The U.S. Food and Drug Administration got what it wanted the makers of FDA-approved testosterone products to do this past spring. The manufacturers updated the labels on all approved prescription testosterone products to do the following:
Testosterone product labels updated
The U.S. Food and Drug Administration got what it wanted the makers of FDA-approved testosterone products to do this past spring. The manufacturers updated the labels on all approved prescription testosterone products to do the following:
Recent science addresses Xarelto bleeding risk
Two professional journal articles released during the week of June 15 underscore the reason that patients who used the anticoagulant Xarelto suffered serious injury. Those scholarly pieces also somewhat vindicated victims or the family members of decedents who have filed Xarelto lawsuits.
